Panagora Asset Management Inc Bluebird Bio, Inc. Transaction History

Panagora Asset Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$1.32 - $4.83 $315,812 - $1.16 Million	-239,252 Reduced 67.85%	113,362 $156,000
Q3 2023 Oct 31, 2023	BUY	$3.02 - $4.05 $33 - $44	11 Added 0.0%	352,614 $1.07 Million
Q2 2023 Aug 11, 2023	BUY	$2.79 - $5.03 $84,542 - $152,419	30,302 Added 9.4%	352,603 $1.16 Million
Q1 2023 May 11, 2023	BUY	$3.14 - $8.22 $265,116 - $694,031	84,432 Added 35.5%	322,301 $1.02 Million
Q4 2022 Feb 13, 2023	BUY	$5.77 - $8.49 $592,792 - $872,237	102,737 Added 76.03%	237,869 $1.65 Million
Q3 2022 Nov 14, 2022	BUY	$3.75 - $7.39 $506,745 - $998,625	135,132 New	135,132 $855,000
Q3 2021 Nov 10, 2021	SELL	$11.24 - $21.0 $43,026 - $80,388	-3,828 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$16.59 - $33.89 $63,506 - $129,730	3,828 New	3,828 $115,000
Q4 2020 Feb 10, 2021	SELL	$27.5 - $37.92 $61,242 - $84,447	-2,227 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$99.64 - $127.59 $910,012 - $1.17 Million	-9,133 Reduced 80.4%	2,227 $350,000
Q1 2018 May 15, 2018	BUY	$105.8 - $150.94 $966,271 - $1.38 Million	9,133 Added 410.1%	11,360 $1.94 Million
Q3 2017 Nov 14, 2017	BUY	$57.74 - $91.42 $128,586 - $203,592	2,227	2,227 $306,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.